11 research outputs found
Energy Resolution Performance of the CMS Electromagnetic Calorimeter
The energy resolution performance of the CMS lead tungstate crystal electromagnetic calorimeter is presented. Measurements were made with an electron beam using a fully equipped supermodule of the calorimeter barrel. Results are given both for electrons incident on the centre of crystals and for electrons distributed uniformly over the calorimeter surface. The electron energy is reconstructed in matrices of 3 times 3 or 5 times 5 crystals centred on the crystal containing the maximum energy. Corrections for variations in the shower containment are applied in the case of uniform incidence. The resolution measured is consistent with the design goals
Does regional belonging explain the similarities in the expenditure determinants of Italian healthcare deliveries? An approach based on Artificial Neural Networks
The investigation of the determinants of public health expenditure is the focus of a vivid debate among health economists whereas the actual crisis of the welfare systems calls for the adoption of innovative tools to inform rational decisions, in the light of stringent budget constraints. The purpose of this paper is to show the potentialities of Artificial Neural Networks (ANNs) in investigating whether healthcare providers belonging to the same jurisdiction show similarities in their health care expenditure determinants. Similarities are reproduced in terms of fuzzy dependencies between health budgetary data of the healthcare providers belonging to five Italian regions. The analysis carried out sees the application of Auto Contractive Maps (AutoCM) model. The methodology is effective in illustrating regional patterns of expenditure and similarities across Local Health Units (Aziende Sanitarie Locali—ASLs). The results give interesting insights on the presence of notable regional models for health expenditure. © 2017 Economic Society of Australia, Queenslan
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory.
Artificial Neural Network
Detection of cow milk in donkey milk by chemometric procedures on triacylglycerol stereospecific analysis results
Study of Some Experimental Parameters in the Synthesis of Triacylglycerols with CLA Isomers and Structural Analysis
Enzymatic Synthesis of Structured Triacylglycerols Containing CLA Isomers Starting from sn-1,3-Diacylglycerols
Dynamic CuII/CuI speciation in Cu-CHA catalysts by in situ Diffuse Reflectance UV–vis-NIR spectroscopy
Dynamics and Flexibility of Human Aromatase Probed by FTIR and Time Resolved Fluorescence Spectroscopy
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore)
Objective: This study aimed to assess the role of Tocilizumab therapy (TCZ) in terms of ICU admission and mortality rate of critically ill patients with severe COVID-19 pneumonia. Design: Patients with COVID-19 pneumonia were prospectively enrolled in SMAtteo COvid19 REgistry (SMACORE). A retrospective analysis of patients treated with TCZ matched using propensity score to patients treated with Standard Of Care (SOC) was conducted. Setting: The study was conducted at IRCCS Policlinico San Matteo Hospital, Pavia, Italy, from March 14, 2020 to March 27, 2020. Participants: Patients with a confirmed diagnosis of COVID-19 hospitalized in our institution at the time of TCZ availability. Interventions: TCZ was administered to 21 patients. The first administration was 8 mg/kg (up to a maximum 800 mg per dose) of Tocilizumab intravenously, repeated after 12 h if no side effects were reported after the first dose. Main Outcomes and Measures: ICU admission and 7-day mortality rate. Secondary outcomes included clinical and laboratory data. Results: There were 112 patients evaluated (82 were male and 30 were female, with a median age of 63.55 years). Using propensity scores, the 21 patients who received TCZ were matched to 21 patients who received SOC (a combination of hydroxychloroquine, azithromycin and prophylactic dose of low weight heparin). No adverse event was detected following TCZ administration. This study found that treatment with TCZ did not significantly affect ICU admission (OR 0.11; 95% CI between 0.00 and 3.38; p = 0.22) or 7-day mortality rate (OR 0.78; 95% CI between 0.06 and 9.34; p = 0.84) when compared with SOC. Analysis of laboratory measures showed significant interactions between time and treatment regarding C-Reactive Protein (CRP), alanine aminotransferase (ALT), platelets and international normalized ratio (INR) levels. Variation in lymphocytes count was observed over time, irrespective of treatment. Conclusions: TCZ administration did not reduce ICU admission or mortality rate in a cohort of 21 patients. Additional data are needed to understand the effect(s) of TCZ in treating patients diagnosed with COVID-19